摘要
目的 观察和评价卡铂联合新型白细胞介素 - 2治疗恶性胸腔积液的临床疗效。 方法 4 2例恶性胸腔积液患者随机分为治疗组和对照组 ,先抽尽胸液 ,之后治疗组胸腔注入卡铂 +新型白细胞介素 - 2 ,对照组单独胸腔注入卡铂 ,每周 1次 ,3～ 4周为 1疗程 ,4周后观察疗效。 结果 治疗组总有效率为 86 .3% ,对照组总有效率 5 5 % ,两组比较有显著差异性 (P <0 .0 5 )。 结论 卡铂联合新型白细胞介素 - 2治疗恶性胸腔积液疗效满意。
Objective To observe and evaluate the clinical effect of carboplatin and new type interleukin-2 in treating malignant thoracic hydrops.Methods 42 cases were randomly divided into treatment group and control group.Firstly withdraw all the thoracic hydrops,after that the treatment group was injected carboplatin and new type interleukin-2,control group was injected Cardoplatin once aweek,3～4 weeks is one treatment course.4 weeks later,observe the effect.Results total effective rate of treatment group is 86.3% that of control group is 55%.there is obvious difference between them(P< 0.05) .Conclusion carboplatin combined with interleukin-2 is effective in treating malignant thoracic hydrops.
出处
《医药论坛杂志》
2003年第24期22-23,共2页
Journal of Medical Forum
